Top Markets
#1 Tornado Cash Tornado Cash +6.24%
#2 Story Story +4.55%
#3 UnifAI Network UnifAI Network +4.47%
#4 TENDIES TENDIES +3.72%
#5 Dual Dual +2.92%
#6 Seeker Seeker +2.82%
#7 Cash Cat Cash Cat +2.58%
#8 Figure Heloc Figure Heloc +2.55%
#9 HOME HOME +2.38%
#10 Orochi Network Orochi Network +2.35%
Coin of the day
Tornado Cash Tornado Cash
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Guiyang Xintian Pharmaceutical Co.,Ltd. Guiyang Xintian Pharmaceutical Co.,Ltd.

Guiyang Xintian Pharmaceutical Co.,Ltd.

002873
Clasificación en acciones #16429
Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the... Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the research, development, production, and commercialization of traditional Chinese medicines (TCMs) for a wide range of ailments. Its product offerings include various pharmaceutical formulations such as hard capsules, gels, mixtures, granules, and tablets. These medicines are specifically designed to treat diverse medical conditions, including antitumor applications, gynecological issues, urinary tract problems, breast and thyroid disorders, blood-related illnesses, heat-related syndromes, oral health complaints, common colds, and cardiovascular diseases. The company was founded in 1995 and is headquartered in Guiyang, China.
Precio por acción
$1.25
Última sincronización: 2026-09-01
Capitalización bursátil
$294.61M
Cambio (1 día)
0.23%
Cambio (1 año)
-26.91%
País
CN
Comercio Guiyang Xintian Pharmaceutical Co.,Ltd. (002873)

Categoría

Healthcare
Ganancias de Guiyang Xintian Pharmaceutical Co.,Ltd. (002873)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Guiyang Xintian Pharmaceutical Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Guiyang Xintian Pharmaceutical Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH